Microbot Medical Inc.
MBOT
$1.55
-$0.13-7.74%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -44.54% | 103.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.94% | 7.17% | |||
| Operating Income | -4.40% | -7.17% | |||
| Income Before Tax | -5.98% | 3.16% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.98% | 3.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.98% | 3.16% | |||
| EBIT | -4.40% | -7.17% | |||
| EBITDA | -4.36% | -7.19% | |||
| EPS Basic | -6.21% | 30.78% | |||
| Normalized Basic EPS | -6.21% | 30.75% | |||
| EPS Diluted | -6.21% | 30.78% | |||
| Normalized Diluted EPS | -6.21% | 30.75% | |||
| Average Basic Shares Outstanding | -0.22% | 39.94% | |||
| Average Diluted Shares Outstanding | -0.22% | 39.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||